Market Overview:
The global T-cell therapy market exhibited strong growth during 2015-2020. T-cell therapy is an immunotherapy approach, known as adoptive cell transfer (ACT), wherein the immune cells from the body of the patient are utilized to treat cancer. It involves collecting T-cells via apheresis and re-engineering them in a laboratory. These re-engineered cells are then multiplied and infused into the body to recognize and kill cancer cells with targeted antigens on their surface. Presently, a growing number of T-cell therapies are undergoing clinical studies. One such study includes the development of an off-the-shelf approach that collects immune cells from healthy donors and makes them available for immediate use.
The growing consumption of tobacco products, unhealthy dietary patterns and sedentary lifestyles are among the key factors escalating the risk of developing cancer. This, in confluence with the rising number of individuals diagnosed with bone marrow and blood-forming tissue diseases, represents one of the major factors catalyzing the demand for T-cell therapies. Moreover, the mass spread of coronavirus disease (COVID-19) has encouraged researchers worldwide to adopt T-cell therapies for treating high-risk patients. Apart from this, the rising awareness among individuals about medical services, in confluence with favorable government policies and regulations, is also propelling the market growth. Additionally, the United States Food and Drug Administration (USFDA) recently approved T-cell therapies to treat children with acute lymphoblastic leukemia (ALL) and adults with advanced lymphomas. This, in turn, is anticipated to provide lucrative opportunities to manufacturers and stimulate the market growth. Looking forward, IMARC Group expects the global T-cell therapy market to grow at a CAGR of around 15% during the forecast period (2021-2026).
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global T-cell therapy market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, modality, therapy type and indication.
Breakup by Modality:
Breakup by Therapy Type:
- CAR T-cell based
- T Cell Receptor (TCR) based
- Tumor Infiltrating Lymphocytes (TIL) based
Breakup by Indication:
- Hematologic Malignancies
- Lymphoma
- Leukemia
- Myeloma
- Solid Tumors
- Melanoma
- Brain and Central Nervous System
- Liver Cancer
- Others
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Aurora Biopharma Inc., bluebird bio Inc, Bristol-Myers Squibb Company, Fate Therapeutics, Gilead Sciences Inc., Merck KGaA, Mustang Bio Inc. (Fortress Biotech Inc.), Novartis AG, Pfizer Inc., Sorrento Therapeutics Inc. and TCR2 Therapeutics.
Key Questions Answered in This Report:
- How has the global T-cell therapy market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global T-cell therapy market?
- What are the key regional markets?
- What is the breakup of the market based on the modality?
- What is the breakup of the market based on the therapy type?
- What is the breakup of the market based on the indication?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global T-cell therapy market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global T-cell Therapy Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Modality
6.1 Research
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Commercialized
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Therapy Type
7.1 CAR T-cell based
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 T Cell Receptor (TCR) based
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Tumor Infiltrating Lymphocytes (TIL) based
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Indication
8.1 Hematologic Malignancies
8.1.1 Market Trends
8.1.2 Key Segments
8.1.2.1 Lymphoma
8.1.2.2 Leukemia
8.1.2.3 Myeloma
8.1.3 Market Forecast
8.2 Solid Tumors
8.2.1 Market Trends
8.2.2 Key Segments
8.2.2.1 Melanoma
8.2.2.2 Brain and Central Nervous System
8.2.2.3 Liver Cancer
8.2.2.4 Others
8.2.3 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Amgen Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Aurora Biopharma Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 bluebird bio Inc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bristol-Myers Squibb Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Fate Therapeutics
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Gilead Sciences Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Merck KGaA
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Mustang Bio Inc. (Fortress Biotech Inc.)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Novartis AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Pfizer Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Sorrento Therapeutics Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.12 TCR2 Therapeutics
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
List of Figures
Figure 1: Global: T-cell Therapy Market: Major Drivers and Challenges
Figure 2: Global: T-cell Therapy Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Global: T-cell Therapy Market: Breakup by Modality (in %), 2020
Figure 5: Global: T-cell Therapy Market: Breakup by Therapy Type (in %), 2020
Figure 6: Global: T-cell Therapy Market: Breakup by Indication (in %), 2020
Figure 7: Global: T-cell Therapy Market: Breakup by Region (in %), 2020
Figure 8: Global: T-cell Therapy (Research) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: T-cell Therapy (Research) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: T-cell Therapy (Commercialized) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: T-cell Therapy (Commercialized) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: T-cell Therapy (CAR T-cell based) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: T-cell Therapy (CAR T-cell based) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: T-cell Therapy (T Cell Receptor-TCR) based) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: T-cell Therapy (T Cell Receptor-TCR) based) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: T-cell Therapy (Tumor Infiltrating Lymphocytes-TIL based) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: T-cell Therapy (Tumor Infiltrating Lymphocytes-TIL based) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: T-cell Therapy (Hematologic Malignancies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: T-cell Therapy (Hematologic Malignancies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: T-cell Therapy (Solid Tumors) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: T-cell Therapy (Solid Tumors) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: T-cell Therapy (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: T-cell Therapy (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: North America: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: North America: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: United States: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: United States: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Canada: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Canada: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Asia-Pacific: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Asia-Pacific: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: China: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: China: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Japan: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Japan: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: India: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: India: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: South Korea: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: South Korea: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Australia: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Australia: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Indonesia: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Indonesia: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Others: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Others: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Europe: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Europe: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Germany: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Germany: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: France: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: France: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: United Kingdom: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: United Kingdom: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Italy: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Italy: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Spain: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Spain: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Russia: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Russia: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Others: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Others: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Latin America: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Latin America: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Brazil: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Brazil: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Mexico: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Mexico: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Others: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Others: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Middle East and Africa: T-cell Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Middle East and Africa: T-cell Therapy Market: Breakup by Country (in %), 2020
Figure 72: Middle East and Africa: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Global: T-cell Therapy Industry: SWOT Analysis
Figure 74: Global: T-cell Therapy Industry: Value Chain Analysis
Figure 75: Global: T-cell Therapy Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: T-cell Therapy Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: T-cell Therapy Market Forecast: Breakup by Modality (in Million US$), 2021-2026
Table 3: Global: T-cell Therapy Market Forecast: Breakup by Therapy Type (in Million US$), 2021-2026
Table 4: Global: T-cell Therapy Market Forecast: Breakup by Indication (in Million US$), 2021-2026
Table 5: Global: T-cell Therapy Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: T-cell Therapy Market: Competitive Structure
Table 7: Global: T-cell Therapy Market: Key Players